Table 5.
Clinical outcomes.
| SCT, n = 59 (15.1%) | LCT, n = 331 (84.9%) | p-Value | |
|---|---|---|---|
| Duration of hospitalization (days) | 7 days (3–34) | 7 days (3–120) | 0.009 |
| Increased severity | 14 (23.7%) | 69 (20.8%) | 0.607 |
| NEWS 96 h after ERCP 5 points or more at 5 to 7 days after ERCP |
0 (0–3) 1/29 (3.4%) |
1 (0–15) 11/226 (4.9%) |
0.45 >0.99 |
| In-hospital mortality due to cholangitis | 0 (0.0%) | 5 (1.5%) | >0.99 |
| Thirty-day mortality | 1 (1.7%) | 11 (3.3%) | >0.99 |
| Three-month recurrence | 4/57 (7.0%) | 36/313 (11.5%) | 0.485 |
| Days required to break the fever after ERCP | 0 (0–8) | 1 (0–23) | <0.001 |
SCT: short-course antibiotic therapy; LCT: long-course antibiotic therapy; NEWS: national early warning score; ERCP: endoscopic retrograde cholangiopancreatography.